AIM2 and systemic lupus erythematosus: AIM2 deficiency in B cells alleviated lupus symptoms and reduced the frequency of CD19+ cells in lymph nodes and spleen, as well as splenic GC B cells and plasmablasts/plasma cells of lymph node via Blimp1-Bcl-6 axis in pristane-induced lupus mice (105).